2 Allali J,D'Hermies F,Renard G.Basal cell carcinomas of the eyelids. Ophthalmologica, 2005,219(2):57~71.
3 Dazard JE,Gal H,Amariglio N, et al. Genomewide comparison of human keratinocyte and squamous cell carcinoma response to UVB irradiation:implication for skin and epithelial cancer. Oncogene, 2003, 22: 2993~3006.
4 Saari KM,Paavilainen V,Tuominen J,et al. Epidemiology of basal cell carcinoma of the eyelid in southwestern Finland.Graefes Arch Clin Exp Ophthalmol, 2001,239(3):230~233.
5 Montironi R,Mazzucchelli R,Stramazzotti D,et al. Basal cell hyperplasia and basal cell carcinoma of the prostate:a comprehensive review and discussion of a case with cerbB2 expression.J Clin Pathol,2005,58 (3):290~296.
6 Kayaselcuk F ,Nursal TZ ,Polat A , et al. Expression of survivin , bcl2 ,p53 and bax in breast carcinoma and ductal intraepithelial neoplasia (DIN 1a). J Exp Clin Cancer Res ,2004 ,23 (1) :105~112.
7 Ryan B ,Konecny G,Kahlert S , et al. Survivin protein expression predicts poor outcome in patients with primary breast cancer ,2005 ASCO Annual Meeting Proceedings. J Clin Oncol ,2005 ,23 (16S) :547.
8 Span PN ,Sweep FC ,Wiegerinck ET , et al.Survivin is an idependent prognostic marker for risk stratification of breast cancer patients. ClinChem,2004 ,50 (11) : 1986~1993.
9 Hoffman WH ,Biade S ,Zilfou JT , et al. Transcriptional repression of the antiapoptotic survivin gene by wild type p53. J Bio Chem, 2002 , 277(5):3247~3257.
10 Ryan B ,O'Donoban N ,Browne B , et al. Expression of survivin and itssplice variants survivin22B and survivin2 △Ex3 in breast cancer. Br JCancer ,2005 ,92 (1) :120~124.
11 Tanaka K,Iwamoto S ,Gon G, et al. Expression of survivin and